Relationship Between the Apheresis Center and the Cell Therapy Developer

The relationship between the apheresis center and cell therapy developer/provider

WEST WARWICK, Rhode Island
May, 2023

An outstanding article from Suzanne Kamps of Adaptimmune in Cell & Gene Therapy Insights on the growing importance of the relationship between the apheresis center and cell therapy developer/provider.

“…clearly communicating our (Adaptimmune) message about our specific treatment and allowing apheresis centers the autonomy to excel in collecting a quality starting material are real priorities for me. I want to continue to advocate for apheresis centers, and to reduce the wait-time for their participation with cell-based therapies.”

Blood Centers of America is excited to be part of the advanced therapy ecosystem Suzanne Kamps describes, all the way from early-stage development through to commercial scale-out.

About Blood Centers of America Blood Centers of America (BCA) is a member-owned organization comprised of over 50 independent blood centers throughout the North America, representing nearly 40% of the U.S. blood supply. Along with their core business of providing a substantial portion of U.S. blood supply, other BCA member services include patient blood management, transfusion services, immunohematology testing, therapeutic apheresis and tissue and cord blood banking. In addition, BCA members provide a variety of human blood products, cells and tissues to the therapeutic, diagnostic and cell therapy industries.